The use of lidocaine patches

Compendium: Continuing Education For Veterinarians

Volumn 29, Issue 4, 2007, Pages 208-216

  Weil, Ann B ^a   Ko, Jeff ^a   Inoue, Tomo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL DEPRESSANT AGENT; FENTANYL; LIDOCAINE; LOCAL ANESTHETIC AGENT;

ANIMAL; ARTICLE; CAT; DOG; DOSE RESPONSE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADJUVANTS, ANESTHESIA; ADMINISTRATION, TOPICAL; ANESTHETICS, LOCAL; ANIMALS; CATS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FENTANYL; LIDOCAINE; TREATMENT OUTCOME;

CANIS FAMILIARIS;

EID: 34249339794     PISSN: 19408307     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Greenbaum SS, Bernstein FF: Comparison of iontophoresis of lidocaine with a eutectic mixture of lidocaine and prilocaine (EMLA) for topically administered local anesthesia. J Derm Surg Oncol 20(9):579-583, 1994.
2. Rowbotham MC, Davies PS, Verkempinck C, Galer BS: Lidocaine patch: Double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 65(1):39-44, 1996.
3. Gammaitoni AR, Alvarez NA, Galer BS: Safety and tolerability of the lidocaine patch 5%. A targeted peripheral analgesic: A review of the literature. J Clin Pharmacol 43:111-117, 2003.
4. Pasero C: Pain control: Lidocaine patch 5%. Am J Nurs 103(9):75-78, 2003.
5. Gammaitoni AR, Galer BS, Onawola R, et al: Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: Results of a pilot 2-week, open-label study using the neuropathic pain scale. Curr Med Res Opin 20(suppl 2):13-19, 2004.
6. Davis MD, Sandroni P: Lidocaine patch for pain of erythromelalgia. Arch Dermatol 138(1):17-19, 2002.
7. Galer BS, Sheldon E, Patel N, et al: Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis. Curr Med Res Opin 20(9):1455-1458, 2004.
8. Adolor corporation announces initiation of phase 2 clinical trial for sterile lidocaine patch. Accessed February 2007 at www.adolor.com.
9. Wallace MS, Dyck JB, Rossi SS, Yaksh TL: Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 66:69-77, 1996.
10. Smith LJ, Shih A, Miletic G, Miletic V: Continual systemic infusion of lidocaine provides analgesia in an animal model of neuropathic pain. Pain 97:267-273, 2002.
11. Weiland L, Croubels S, Baert K, et al: Pharmacokinetics of a lidocaine patch 5% in dogs. J Vet Med A Physiol Pathol Clin Med 53(1):34-39, 2006.
12. Ko JCH, Weil AB, Maxwell LK, et al: Plasma concentration of lidocaine following 5% lidocaine patch application in dogs. JAAHA, scheduled for publication, September/October 2007.
13. Wilson DV, Barnes KS, Hauptman JG: Pharmacokinetics of combined intraperitoneal and incisional lidocaine in the dog following ovariohysterectomy. J Vet Pharmacol Ther 27(2):105-109, 2004.
14. Fujita Y: Comparative direct effects of lidocaine and bupivacaine on regional myocardial function in dogs at noncardiovascular toxic levels. Anesth Analg 78(6):1158-1163, 1994.
15. Ko JCH, Maxwell LK, Abbo LA: Pharmacokinetics of lidocaine following the application of 5% lidocaine patches to cats. Submitted for an oral presentation at the upcoming annual meeting of the American College of Veterinary Clinical Pharmacologists.